Vascular and Metabolic Effects of Hormone Therapy Combined With L-Arginine in Postmenopausal Women

NCT00001752 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

NIH

Sponsor class

Conditions

Hypercholesterolemia
Postmenopause

Interventions

DRUG: L-arginine
DRUG: Estrogen

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)